Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: UNIVERSITAT ST. GALLEN
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2025-09-08 to 2026-09-29
Current total value of award: $515769.89
Description: THE PURPOSE OF THIS CONTRACT IS TO CONDUCT RESEARCH AND DEVELOP TOOLS TO STRENGTHEN POST-MARKET SURVEILLANCE OF FDA-REGULATED PRODUCTS. THE OBJECTIVE IS TO APPLY ADVANCED ANALYTICS AND HYBRID ARTIFICIAL INTELLIGENCE TO IMPROVE RISK IDENTIFICATION USI